Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07642414 · ClinicalTrials.gov registry record · NA
A Comprehensive Digital Care Program for Migraine Management
A NA study, sponsored by Hinge Health.
- Recruiting
- Registry status
- NA
- Development phase
- 140
- Enrollment target
NCT07642414 is a NA study that is actively recruiting participants, run by Hinge Health. The registered enrollment target is 140 participants.
The verdict
NCT07642414, a NA study, is actively recruiting participants, sponsored by Hinge Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
Study Summary
This study evaluates the clinical effectiveness of the Enso for Migraine program, a comprehensive digital care program combining an FDA-cleared neuromodulation wearable device (Enso), personalized exercise therapy, and a dedicated care team, in reducing migraine frequency among adults with episodic or chronic migraine.
Interventions
- DEVICE Neuromodulation Wearable Device
- OTHER Migraine Digital Care Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2026-06 |
| Est. Completion | 2026-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07642414
The ClinicalTrials.gov registry entry for NCT07642414 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hinge Health, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Neuromodulation Wearable Device is the first listed.
NCT07642414 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07642414 about?
NCT07642414 is a clinical study titled "A Comprehensive Digital Care Program for Migraine Management". This study evaluates the clinical effectiveness of the Enso for Migraine program, a comprehensive digital care program combining an FDA-cleared neuromodulation wearable device (Enso), personalized exercise therapy, and a dedicated care team, in reducing migraine frequency among adults with episodic ...
What is the current status of trial NCT07642414?
This trial is currently recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2026-06. Estimated completion is 2026-11.
What interventions are being tested in trial NCT07642414?
The interventions under investigation include: Neuromodulation Wearable Device (DEVICE), Migraine Digital Care Program (OTHER).
Who is sponsoring clinical trial NCT07642414?
This trial is sponsored by Hinge Health, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.